MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests to support cancer treatment. The company utilizes its proprietary, patented DNA methylation platform and biomarkers to offer tests that aid in the improvement of cancer diagnostics, prognosis and treatments for multiple cancer types. For further information, visit the company’s Web site at www.mdxhealth.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: